NCBiotech News

With rapid shifts in the blueberry and cranberry industries calling for higher fruit quality, researchers at North Carolina State University have received funding for a project lead by Massimo Iorizzo at the university's new Plants for Human Health Institute.

Cary-based SAS, a global powerhouse in analytics software and services, is creating a new agricultural technology business unit to help farmers feed a growing global population that is projected to reach 10 billion people by 2050.

As UNC Charlotte biology doctoral student Farida Yasmin advances her research into the wild soybean and its potential to address worldwide food scarcity, she continues to grow her impact and her knowledge.

NCBiotech convened a panel of companies with operations in North Carolina at BIO-Europe 2019 to explore challenges that European life science companies face when setting up shop in the U.S.

Merck announces a $57 million investment at the company's Wilson plant to establish a filling and packaging line for its RotaTeq vaccine. The expansion will increase employment by about 55 jobs over the next two years.

Fertilizer usually means promoting growth of crops. However, Jack Odle, Ph.D., is studying how feeding prebiotics (indigestible fiber parts of foods) to piglets fertilizes the “good” bacteria in their guts and improves their health while also informing nutrition practices for human newborns.

Q2 Solutions, a Morrisville clinical trial laboratory services provider, announced plans today for a new $73 million precision medicine facility in Durham that is expected to create 749 jobs over seven years.

Vestaron, a start-up that recently moved its corporate headquarters to RTP from Kalamazoo, is moving to commercialize the use of bee-safe peptide-based bioinsecticides.

An NCBiotech-sponsored event at ECU called “Capture 180” lets undergraduate students doing mentored research describe their projects in three minutes or less, using one visual aid. No pressure.

Merz announced plans this week to reorganize into three independently operating businesses and Raleigh will be the official global headquarters of the medical aesthetics unit, under CEO Bob Rhatigan.

SQZ Biotechnologies' tolerizing antigen carriers may help expand patient eligibility for AskBio's gene therapies.

Triangle Business Journal released the annual list of the Triangle’s 50 fastest-growing companies, and five life science companies made the cut.

Raybow Pharmaceutical acquires PhamAgra Labs, a custom R&D company in Brevard, and plans to triple the number of employees in the next several years.

The FDA has approved Raleigh-based RedHill Biopharma’s new drug to treat serious gastrointestinal infections after a priority review of the medication.

BioAgilytix, a Durham-based provider of large-molecule bioanalytical testing services, has acquired Cambridge Biomedical, a contract research organization based in the Boston suburb of Cambridge.